ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients.

Abstract

*Cardio-Thoracic Surgery Department, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands; †Adult Intensive Care Unit, The Prince Charles Hospital, Brisbane, Queensland, Australia; ‡CardioThoracic Intensive Care Unit, National University Hospital, Singapore, Singapore; §Medical Intensive Care Unit, Hopital La Pitie’-Salpetriere, University Pierre et Marie Curie, Paris, France; ¶Intensive Care Unit, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia; ║Cardiac Surgery Unit, Gasthuisberg University Hospital, Catholic University, Leuven, Belgium; #Section of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan; **Department of Anesthesia and Intensive Care, IRCCS ISMETT, UPMC, Palermo, Italy; ††Department of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; ‡‡2nd Department of Medicine, Cardiovascular Medicine, General University Hospital, Charles University, Prague, Czech Republic; §§Cardiac Intensive Care, Beijing Anzhem Hospital, Capital Medical University, Beijing, China; ¶¶Department of Cardiac Surgery, Heinrich-Heine-University, Düsseldorf, Germany; ||||Unidad ECMO, Clínica Las Condes, Santiago, Chile; ##Intensive Care Unit, Utrecht University Medical Centre, Utrecht, The Netherlands; ***CRPH Cardiovascular & Respiratory Physiology Group, TechMed Centre, Faculty of Science & Technology, University of Twente, Enschede, The Netherlands; ††† Division of Pulmonology, Allergy and Critical Care, NewYork Presbiterian Hospital, Columbia University, New York, New York; ‡‡‡CardioThoracic and Vascular Anesthesia and ICU Department, IRCCS Policlinico San Donato Hospital, Milan, Italy; §§§Minneapolis Heart Institute Foundation, Abbot Northwestern University, Minneapolis, Minnesota; ¶¶¶Cardiovascular Centre, National Taiwan University Hospital, Taiwan, Taipei; ||||||Department of Intensive Care, Fundación Cardiovascular de Colombia, Bucaramanga, Colombia; ###Cardiovascular Surgery Intensive Care Unit and Heart Transplant, Johns Hopkins Hospital, Baltimore, Maryland; ****University of Sydney, Australia; ††††Santiago del Chile, Chile; ‡‡‡‡University of Regensburg, Germany; and §§§§University of Paris, France. Submitted for consideration March 2021; accepted for publication in revised form March 2021. Dr. Lorusso is the consultant for LivaNova, Getinge, and Medtronic, and member of the Advisory Board of Eurosets (all honoraria for presentation paid to the University for research funding). The remaining authors have no conflicts of interest to report. Correspondence: Roberto Lorusso, MD, PhD, FELSO, FEACTS, Cardiac Surgery and Extracorporeal Life Support, Department of Cardio-Thoracic Surgery, Heart & Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), P. Debyelaan 25, Maastricht 6202 AZ, The Netherlands. E-mail: [email protected]. Copyright © ELSO 2021